Search filters

List of works by Asisa Volz

A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice

scientific article published on 24 December 2019

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells

scientific article

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

scientific article published on 17 December 2015

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

scholarly article by Svenja Veit et al published 16 December 2018 in Viruses

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

scientific article (publication date: 2012)

Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S

scientific article published on 01 July 2018

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox

scientific article published on 4 January 2018

Easy and efficient protocols for working with recombinant vaccinia virus MVA.

scientific article published in January 2012

Generation of therapeutic antisera for emerging viral infections

scientific article published on 05 October 2018

Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8 T cell proliferation

scientific article published on 10 October 2018

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens

scientific article published on 29 February 2016

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice

scientific article

Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.

scientific article published on 26 April 2016

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

scientific article published on 28 August 2013

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

scientific article

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

scientific article

Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine

scientific article published on November 2015

Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals

scientific article published on 15 November 2020

Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara

scientific article published on 10 February 2016

N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection

scientific article

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes

scientific article published on 11 October 2016

Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection

scientific article published on 07 January 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

scientific article published on 27 May 2015

Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

scientific article published on 21 March 2013

Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara

scientific article

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge

scientific article

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

scientific article published on 20 April 2020

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

scientific article

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise

scientific article published on 12 August 2020

Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections

scientific article published on 24 August 2018

Paulina is supported by:

About Paulina

Help